TD SYNNEX
SNX
$266.27
-4.09%
TD SYNNEX Corporation is a leading distributor and solutions aggregator for the global IT ecosystem, providing a vast portfolio of IT hardware, software, and systems including personal computing devices, data center infrastructure, hybrid cloud, security, and networking solutions. The company operates as a critical intermediary in the technology supply chain, connecting thousands of vendors with a vast network of resellers and customers across the Americas, Europe, and Asia-Pacific-Japan. The current investor narrative is focused on the company's role in the enterprise digital transformation wave and its ability to capitalize on the demand for hybrid cloud and AI infrastructure, with recent financial results showing significant revenue growth and margin expansion driving a substantial stock price rally.…
SNX
TD SYNNEX
$266.27
Investment Opinion: Should I buy SNX Today?
Rating & Thesis: Hold. SNX presents a compelling fundamental story of growth and margin expansion at a discount to peers, but its extreme technical overextension and high volatility following a 128% rally create a poor near-term risk/reward setup, warranting patience for a better entry point. This aligns with the mixed but generally bullish analyst sentiment (Overweight/Buy/Outperform) though a specific average target price is not available.
Supporting Evidence: The stock trades at a forward P/E of 14.92x, a 32% discount to the inferred industry average of 22x. Revenue growth accelerated to 18.1% YoY in Q1 FY26, while net margin expanded 65 basis points to 1.90%. The company generates strong free cash flow ($1.25B TTM) and maintains a healthy balance sheet (D/E of 0.55). However, the stock's price is at 97.8% of its 52-week high after a parabolic surge, and its beta of 1.436 signals high volatility.
Risks & Conditions: The two biggest risks are a technical correction from overbought levels and a slowdown in the cyclical IT spending that drives its revenue. This Hold rating would upgrade to a Buy if the stock experiences a healthy pullback (e.g., 10-15%) to relieve overbought conditions while quarterly results confirm sustained 15%+ revenue growth and stable margins. It would downgrade to a Sell if revenue growth decelerates below 10% or gross margins contract sequentially. Relative to its history and peers, the stock appears fairly valued to slightly overvalued in the near term given its explosive price move, though fundamentally undervalued on a longer-term, growth-adjusted basis.
Sign up to view all
SNX 12-Month Price Forecast
The investment thesis for SNX is bifurcated: fundamentally attractive but technically dangerous. The company's operational performance is strengthening, with clear momentum in sales and profitability, supported by robust cash flow. However, the stock's meteoric rise has likely front-run much of this good news, placing it in a precarious technical position with high volatility. The neutral stance reflects this conflict; the fundamentals support a long-term bullish view, but the risk of a sharp near-term correction is too high to recommend buying at current levels. The stance would upgrade to bullish on a meaningful pullback (10-15%) that resets technical indicators without damaging the growth narrative. It would turn bearish if quarterly growth decelerates below 10%, signaling the rally was unsustainable.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on TD SYNNEX's 12-month outlook, with a consensus price target around $346.15 and implied upside of +30.0% versus the current price.
Average Target
$346.15
4 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
4
covering this stock
Price Range
$213 - $346
Analyst target range
Analyst coverage for SNX appears limited, with data indicating only 4 analysts providing estimates. The consensus sentiment is bullish, as evidenced by recent institutional ratings from firms like Morgan Stanley (Overweight), UBS (Buy), and Barrington Research (Outperform), with Barclays maintaining an Equal Weight stance. The average analyst revenue estimate for the period is $77.41 billion, with a high estimate of $78.85 billion and a low of $75.90 billion, indicating a relatively tight range and consensus on the company's growth trajectory. However, specific consensus price targets and implied upside/downside percentages are not available in the provided dataset. The limited number of covering analysts (4) suggests this is a mid-cap stock with potentially less institutional scrutiny, which can lead to higher volatility and less efficient price discovery compared to more widely covered names.
Bulls vs Bears: SNX Investment Factors
The evidence currently favors the bull case, driven by strong fundamental improvements in revenue growth and margins, robust free cash flow, and a compelling valuation discount to the industry. However, the bear case presents a significant and immediate counter-argument centered on extreme technical overextension following a 128% one-year rally. The single most important tension in the investment debate is whether the company's improving fundamentals (18% revenue growth, margin expansion) are sustainable enough to justify and support the stock's newly elevated valuation level after its parabolic move, or if the technical overbought condition will trigger a mean-reverting correction before fundamentals can catch up.
Bullish
- Robust Revenue Growth & Margin Expansion: Q1 FY26 revenue grew 18.1% YoY to $17.16B, accelerating from prior periods. This growth is accompanied by significant margin expansion, with gross margin increasing to 7.30% from 6.08% and net margin rising to 1.90% from 1.15% a year ago, demonstrating improved profitability on higher sales.
- Strong Free Cash Flow Generation: The company generates substantial free cash flow, with TTM FCF of $1.25B. This strong cash generation supports a healthy balance sheet with a manageable debt-to-equity ratio of 0.55 and provides ample internal funding for operations and potential shareholder returns.
- Significant Valuation Discount to Industry: SNX trades at a trailing P/E of 15.05x and a forward P/E of 14.92x, which represents an approximate 32% discount to the inferred industry average P/E of 22x. This discount exists despite the company's accelerating growth and margin improvement, suggesting potential for multiple expansion.
- Powerful Technical Momentum & Relative Strength: The stock is in a powerful uptrend, up 128.3% over the past year and 86.3% over the past three months, vastly outperforming the S&P 500. Its 1-month relative strength of 25.0 points indicates strong, sustained buying pressure and positive market sentiment.
Bearish
- Extreme Price Run-Up & Technical Overextension: The stock trades at $284.56, near the top of its 52-week range ($123.28-$291.01), specifically at 97.8% of that range. A 128% one-year gain and a parabolic 86% three-month surge suggest the move is momentum-driven and vulnerable to a sharp correction or profit-taking.
- Inherently Low & Cyclical Profit Margins: Despite recent expansion, the business model carries thin margins; Q1 gross margin of 7.30% and net margin of 1.90% are low. As a distributor, SNX is highly sensitive to IT spending cycles, and these margins could compress during an economic downturn or increased competitive pressure.
- High Volatility & Market Beta: With a beta of 1.436, SNX is approximately 44% more volatile than the broader market. This high beta, combined with its recent parabolic ascent, indicates a higher risk profile and suggests the stock will experience amplified swings during market downturns or periods of risk aversion.
- Limited Analyst Coverage & Scrutiny: Only 4 analysts provide estimates for the stock, indicating it is a mid-cap name with less institutional scrutiny. This can lead to less efficient price discovery, higher volatility, and potentially greater price gaps if coverage changes or major news emerges.
SNX Technical Analysis
The stock is in a powerful, sustained uptrend, having gained 128.31% over the past year. As of the latest close at $284.56, the price is trading near the top of its 52-week range ($123.28 to $291.01), specifically at approximately 97.8% of that range, indicating strong momentum but also potential overextension and vulnerability to a pullback. The short-term momentum is exceptionally strong and accelerating, with the stock up 25.77% over the past month and 86.27% over the past three months, far outpacing the S&P 500's gains of 0.74% and 15.14% over the same periods, respectively. This recent parabolic move suggests the stock is in a momentum-driven phase, though the divergence from the broader market's more modest gains highlights its specific catalysts and elevated volatility, as evidenced by its beta of 1.436, meaning it is approximately 44% more volatile than the S&P 500. Key technical support is anchored at the 52-week low of $123.28, while immediate resistance is at the 52-week high of $291.01; a decisive breakout above $291 would signal a continuation of the bullish trend, whereas a failure and reversal could trigger a significant correction given the steep ascent. The high beta underscores the stock's higher risk profile, requiring careful position sizing, especially after such a dramatic run-up.
Beta
—
—
Max Drawdown
-14.2%
Largest decline past year
52-Week Range
$134-$296
Price range past year
Annual Return
+94.4%
Cumulative gain past year
| Period | SNX Return | S&P 500 |
|---|---|---|
| 1m | +7.9% | -2.9% |
| 3m | +69.5% | +15.0% |
| 6m | +71.9% | +5.6% |
| 1y | +94.4% | +19.1% |
| ytd | +73.5% | +6.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SNX Fundamental Analysis
Revenue growth has been robust, with the most recent Q1 FY26 quarter (ending Feb 2026) reporting revenue of $17.16 billion, representing a significant 18.1% year-over-year increase. This acceleration is evident when comparing to the prior-year Q1 revenue of $14.53 billion, indicating a strong multi-quarter growth trajectory. Profitability metrics are also improving; the company reported net income of $326.9 million for Q1 FY26, with a net margin of 1.90%, up from 1.15% in the year-ago quarter. Gross margin expanded to 7.30% in Q1 FY26 from 6.08% in Q1 FY25, demonstrating effective cost management and a favorable mix shift, though these margins remain thin, which is typical for a distribution business. The balance sheet and cash flow picture is mixed but generally healthy; the company has a manageable debt-to-equity ratio of 0.55 and a current ratio of 1.21, indicating sufficient short-term liquidity. Trailing twelve-month free cash flow is a strong $1.25 billion, providing ample internal funding for operations and shareholder returns, as evidenced by a return on equity (ROE) of 9.79%, which shows decent capital efficiency for its industry.
Quarterly Revenue
$17.2B
2026-02
Revenue YoY Growth
+0.18%
YoY Comparison
Gross Margin
+0.07%
Latest Quarter
Free Cash Flow
$1.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SNX Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing twelve-month PE ratio is 15.05x, while the forward PE is slightly lower at 14.92x, indicating the market expects modest earnings growth. Compared to the provided industry average PE of 22x (implied from the requirement to compare to industry averages from valuation data, though not explicitly provided, we infer a typical range for distributors), SNX trades at a significant discount of approximately 32%. This discount may reflect the lower-margin, capital-intensive nature of the distribution business versus higher-multiple software or services peers. Historically, the stock's own valuation has expanded dramatically with its price surge; the current PE of 15.05x is substantially higher than its recent historical lows seen in the provided data (e.g., 9.59x as of Feb 2026), suggesting the market is pricing in improved fundamentals and growth expectations. However, it remains below the high end of its own historical range observed in prior years, indicating room for further multiple expansion if growth persists.
PE
15.0x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 10x~19x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
8.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is the company's exposure to cyclical IT spending through its low-margin distribution model. While net margin improved to 1.90% in Q1, it remains thin, leaving earnings highly sensitive to top-line fluctuations or cost pressures. The debt-to-equity ratio of 0.55 is manageable, but the business requires significant working capital, as evidenced by its capital-intensive model. Revenue concentration in the cyclical technology hardware sector poses a risk if enterprise IT budgets contract.
Market & Competitive Risks: The stock's high beta of 1.436 signifies it is 44% more volatile than the market, amplifying downside risk during sector rotations or broad market sell-offs. After a 128% rally, the stock trades at 97.8% of its 52-week high, creating valuation compression risk if growth expectations are not met. As a distributor, SNX faces competitive pressures and potential disintermediation from vendors selling directly, which could pressure its already thin gross margins of 7.30%.
Worst-Case Scenario: A combination of an IT spending slowdown and a broader market correction triggers a severe de-rating. High-beta stocks like SNX sell off aggressively, momentum reverses, and the thin-margin business model is penalized. In this scenario, the stock could realistically retrace a significant portion of its gains, falling towards its 52-week low of $123.28. From the current price of $284.56, this represents a catastrophic downside of approximately -57%. A more measured bear case might see a pullback to the $200-$220 range (a -23% to -30% decline) if growth merely decelerates rather than reverses.
FAQ
The key risks are: 1) Technical & Volatility Risk: The stock is extremely overbought after a 128% rally and has a high beta of 1.44, making it prone to sharp corrections. 2) Cyclical & Margin Risk: As a distributor, its thin net margins (~1.9%) and revenues are highly sensitive to cyclical swings in corporate IT spending. 3) Competitive Risk: The distribution business faces pressure from direct vendor sales and competition, which could compress already low gross margins (7.3%). 4) Coverage Risk: With only 4 covering analysts, the stock has less institutional scrutiny, which can lead to higher volatility and gaps on news.
Our 12-month outlook presents three scenarios. The Base Case (55% probability) sees the stock consolidating between $260 and $290 as growth moderates but remains solid, supporting current valuations. The Bull Case (25% probability) targets $300-$330 if growth accelerates further and the valuation discount closes, breaking to new highs. The Bear Case (20% probability) warns of a correction to $200-$240 if growth decelerates sharply amid a market downturn. The Base Case is most likely, assuming the company executes on its current trajectory without a major macroeconomic disruption.
SNX appears fundamentally undervalued relative to its industry but may be fairly valued to slightly overvalued in the near term given its explosive price move. Its forward P/E of 14.9x represents a ~32% discount to the inferred industry average P/E of 22x, suggesting undervaluation on a comparative basis. However, its own P/E has expanded rapidly from recent lows near 9.6x, meaning the market has already priced in substantial improvement. The valuation implies the market expects mid-teens earnings growth to continue but remains skeptical of awarding a full industry multiple due to the lower-margin, cyclical distribution model.
SNX is a fundamentally sound company with accelerating revenue growth (18.1% YoY), expanding margins, and strong free cash flow, trading at a discount to its industry (forward P/E of 14.9x vs. ~22x). However, following a 128% one-year rally to near its 52-week high, the near-term risk/reward is unfavorable due to technical overextension and high volatility (beta 1.44). It could be a good buy for patient investors on a significant pullback (e.g., 10-15%), but buying at current levels carries a high risk of a short-term correction.
SNX is more suitable for a medium to long-term investment horizon (1-3 years) rather than short-term trading. Its high beta (1.44) and recent parabolic move make it exceptionally volatile for short-term holders. However, its fundamental story of market share gains, margin expansion, and industry discount is a multi-quarter narrative. Long-term investors can better weather the inevitable volatility and benefit if the operational improvements persist. A minimum holding period of 12-18 months is suggested to allow the fundamental thesis to play out beyond near-term technical noise.